Glut-1 Antibody (YA7379)
(Synonyms: GLUT1, SLC2A1, HepG2 glucose transporter, GLUT-1)Based on 1 publication(s) in Google Scholar
Glut-1 Antibody (YA7379) is a Rabbit-derived and non-conjugated IgG, Kappa monoclonal antibody, targeting to Glut-1.
-
Host:
Rabbit
-
Isotype:
IgG
-
Application:
WB, IHC-P, ICC/IF, ELISA
-
Reactivity :
Human, Mouse, Rat
-
Formulation:
Supplied in PBS (pH7.4) containing 50% glycerol, 0.05% Proclin 300, 0.05%BSA
-
Conjugation:
Non-conjugated
Publications Citing Use of MedChemExpress (MCE) Glut-1 Antibody (YA7379)
More
Applications
| Application |
IHC-P
IHC-P: Immunohistochemistry-Paraffin
|
WB
WB: Western Blot
|
ICC/IF
ICC/IF: Immunocytochemistry/
Immunofluorescence |
ELISA
ELISA: Enzyme Linked Immunosorbent Assay
|
|---|---|---|---|---|
| Dilution Ratio | 1:1000-1:5000 | 1:10000-1:50000 | 1:200-1:1000 | 1:5000-1:20000 |
Product Details
Glut-1 Antibody (YA7379) is a Rabbit-derived and non-conjugated IgG, Kappa monoclonal antibody, targeting to Glut-1.
-
Host Rabbit
-
Clonality Monoclonal,Recombinant
-
Species ReactivityHuman, Mouse, Rat
-
Observed Molecular WeightObserved band size: 50-300 kDaNote: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
-
Calculated Molecular Weight Predicted band size: 54 kDa
The exact sequence is proprietary to MCE.
Endogenous
Protein A affinity purified
Non-conjugated
Unmodified
IgG
Product Properties
-
Appearance
Solution
-
Formulation
Supplied in PBS (pH7.4) containing 50% glycerol, 0.05% Proclin 300, 0.05%BSA
-
Concentration
Batch-dependent, Please check the COA for the concentration of each lot. Check Lot Concentration
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Chem Biol Interact
A microfluidic human blood-brain barrier model reveals neurovascular toxicity and barrier disruption induced by E-cigarette additives. [Abstract]2026 Aug 1:436:112206. PMID: 42285244
Background
-
Function
GLUT1 (SLC2A1) provides basal glucose uptake and supports cellular glucose transport across physiological and pathological contexts[1]. Mechanistically, GLUT1 belongs to the sugar porter family, where glucose transport depends on conserved substrate coordination and conformational regulation[2]. In disease models, impaired GLUT1 function causes Glut1 deficiency syndrome, a brain energy failure syndrome driven by reduced glucose transport across brain tissue barriers[3][4]. Compared with GLUT3, GLUT1 shares a conserved substrate-binding site but differs in transport affinity, making isoform distinction essential for transporter-specific experimental design[2]. GLUT1 and GLUT3 also transport dehydroascorbic acid, whereas GLUT2, GLUT5, and SGLT1 do not transport DHA in the tested oocyte system[5]. For experimental applications, WZB117 inhibits GLUT1-mediated sugar transport and downregulates glycolysis, supporting its use in glucose uptake and cancer metabolism studies[6][7].
-
Subcellular Localization
Cell membrane,Melanosome,Photoreceptor inner segment
-
Expression
Tissue_Specificity: Detected in erythrocytes (at protein level). Expressed at variable levels in many human tissues -
Isoforms & Post-Translational Modification
P11166: 492 amino acids, molecular weight 54084 Da.
-
Subunit
Interacts with GIPC (via PDZ domain) (By similarity)
-
SwissProt ID
-
Synonyms
GLUT1, SLC2A1, HepG2 glucose transporter, GLUT-1
Documentation
-
Data Sheet (261 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
User Guide for Antibodies (1077 KB)
References
[1]. Pragallapati S, et al. Glucose transporter 1 in health and disease. J Oral Maxillofac Pathol. 2019 Sep-Dec;23(3):443-449. [Content Brief]
[2]. Custódio TF, et al. Structural comparison of GLUT1 to GLUT3 reveal transport regulation mechanism in sugar porter family. Life Sci Alliance. 2021 Feb 3;4(4):e202000858. [Content Brief]
[3]. Klepper J, et al. Glut1 Deficiency Syndrome (Glut1DS): State of the art in 2020 and recommendations of the international Glut1DS study group. Epilepsia Open. 2020 Aug 13;5(3):354-365. [Content Brief]
[4]. Tang M, et al. Brain microvasculature defects and Glut1 deficiency syndrome averted by early repletion of the glucose transporter-1 protein. Nat Commun. 2017 Jan 20;8:14152. [Content Brief]
[5]. Rumsey SC, et al. Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid. J Biol Chem. 1997 Jul 25;272(30):18982-9. [Content Brief]
[6]. Liu Y, et al. A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo. Mol Cancer Ther. 2012 Aug;11(8):1672-82. [Content Brief]
[7]. Ojelabi OA, et al. WZB117 (2-Fluoro-6-(m-hydroxybenzoyloxy) Phenyl m-Hydroxybenzoate) Inhibits GLUT1-mediated Sugar Transport by Binding Reversibly at the Exofacial Sugar Binding Site. J Biol Chem. 2016 Dec 23;291(52):26762-26772. [Content Brief]